Soman R, Chakraborty S, Joe G. Posaconazole or Isavuconazole as sole or predominant anti-fungal therapy for COVID-19 associated Mucormycosis. A retrospective observational case series. Int J Infect Dis 2022 Apr 8. pii: S1201-9712(22)00208.
PMID: 35405351